Major surgical trauma induces proteolysis of insulin-like growth factor binding protein-3 in transgenic mice and is associated with a rapid increase in circulating levels of matrix metalloproteinase-9

Surgical Endoscopy and Other Interventional Techniques

Volumn 21, Issue 4, 2007, Pages 653-658

  Belizon, A ^a   Kirman, I ^a   Balik, E ^a   Karten, M ^a   Jain, S ^a   Whelan, R L ^a  

^a Department of Medicine   (United States)

Author keywords

IGFBP 3; Laparotomy; MMP 9; Pneumoperitoneum; Surgical trauma

Indexed keywords

GELATINASE B; SOMATOMEDIN BINDING PROTEIN 3;

ANESTHESIA INDUCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CELL LYSATE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; LAPAROTOMY; MAJOR SURGERY; MEDICAL ASSESSMENT; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PNEUMOPERITONEUM; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN INDUCTION; SURGICAL INJURY; TRANSGENIC MOUSE; TRANSGENICS; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; LAPAROTOMY; MATRIX METALLOPROTEINASE 8; MICE; MICE, TRANSGENIC; PNEUMOPERITONEUM, ARTIFICIAL; POSTOPERATIVE PERIOD; PROBABILITY; RANDOM ALLOCATION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; STRESS;

EID: 33947306615     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-006-9103-x     Document Type: Article

References (38)

1. Parkin DM, Pisani P, Ferlay J (1999) Global cancer statistics. CA Cancer J Clin 49: 33-64
2. Vermoken JB, Claessen AM, van Tinteren H, Gall HE, Ezinga R, Meijer S, Scheper RJ, Meijer CJ, Bloemena E, Ransom JH, Hanna MG Jr, Pinedo HM (1999) Active specific immunotherapy for stage 2 and stage 3 human colon cancer: a randomized trial. Lancet 353: 345-350
3. Jagoditsch M, Lisborg PH, Jatzgo GR, Wette V, Kropfitsch G, Denk H, Klimpfinger M, Stettner HM (2000) Long-term prognosis for colon cancer related to consistent radical surgery: multivariate analysis of clinical, surgical, and pathologic variables. World J Surg 24: 1264-1270
4. Weese JL, Ottery FD, Emoto SE (1986) Do operations facilitate tumor growth? An experimental model in rats. Surgery 100: 273-277
5. Eggermont AM, Steller EP, Marquet RL, Jeekel J, Sugarbaker PH (1988) Local regional promotion of tumor growth after abdominal surgery is dominant over immunotherapy with interleukin-2 and lymphokine-activated killer cells. Cancer Detect Prev 12: 421-429
6. Goshima H, Saji S, Furata T, Taneumura H, Takao H, Kida H, Takahashi H (1989) Experimental study on preventive effects of lung metatastases using LAK cells induced from various lymphocytes: special references to enhancement of lung metastasis after laparotomy stress. J Jap Surg Soc 90: 1245-1250
7. 2 pneumoperitoneum and the inhibition of metastases utilizing perioperative immunomodulation and a tumor vaccine. Surg Endosc 16: 1162-1169
8. Lee SW, Gleason N, Blanco I, Asi ZK, Whelan RL (2002) Higher colon cancer tumor proliferative index and lower tumor cell death rate in mice undergoing laparotomy versus insufflation. Surg Endosc 16: 36-39
9. 2 pneumoperitoneum. Dis Colon Rectum 42: 477-481
10. Allendorf JD, Bessler M, Kayton ML, Oesterling SD, Treat MR, Nowygrod R, Whelan RL (1995) Increased tumor establishment and growth after laparotomy vs laparoscopy in a murine model. Arch Surg 130: 649-653
11. Da Costa ML, Redmond HP, Finnegan N, Flynn M, Bouchier-Hayes D (1998) Laparotomy and laparoscopy differentially accelerate experimental flank tumor growth. Br J Surg 85: 1439-1442
12. DaCosta ML, Redmond P, Boucher-Hayes DJ (1998) The effect of laparotomy and laparoscopy on the establishment of spontaneous tumor metastases. Surgery 124: 516-525
13. Southall JC, Lee SW, Allendorf JD, Bessler M, Whelan RL (1998) Colon adenocarcinoma and B-16 melanoma grow larger following laparotomy vs pneumoperitoneum in a murine model. Dis Colon Rectum 41: 564-569
14. Allendorf JD, Bessler M, Horvath KD, Marvin MR, Laird DA, Whelan RL (1998) Increased tumor establishment and growth after open versus laparoscopic bowel resection in mice. Surg Endosc 12: 1035-1038
15. Allendorf JDF, Bessler M, Horvath KD, Marvin MR, Laird DA, Whelan RL (1999) Increased tumor establishment and growth after open vs laparoscopic surgery in mice may be related to differences in postoperative T-cell function. Surg Endosc 13: 233-235
16. Lee SW, Gleason N, Blanco I, Asi Z, Whelan RL (2002) Higher colon cancer tumor proliferative index and lower tumor cell death rate in mice undergoing laparotomy versus insufflation. Surg Endosc 16: 36-39
17. Kirman I, Cedik V, Poltaratskaia N, Asi Z, Bessler M, Huang EH, Forde KA, Whelan RL (2002) Plasma from patients undergoing major open surgery stimulates in vitro tumor growth: lower insulin-like growth factor binding protein-3 levels may, in part, account for this change. Surgery 132: 186-192
18. Kirman I, Cekic V, Poltoratskaia N, Sylla P, Jain S, Forde KA, Whelan RL (2005) Open surgery induces a dramatic decrease in circulating intact IGFBP-3 in patients with colorectal cancer not seen with laparoscopic surgery. Surg Endosc 19: 55-59
19. Kirman I, Jain S, Cekic V, Belizon A, Balik E, Sylla P, Arnell T, Forde KA, Whelan RL (2006) Altered plasma matrix metalloproteinase-9/tissue metalloproteinase-1 concentration during the early postoperative period in patients with colorectal cancer. Surg Endosc 20: 482-486
20. Martin JL, Baxter RC (1986) Insulin-like growth factor-binding protein from human plasma: purification and characterization. J Biol Chem 261: 8754-8760
21. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P (1995) The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9: 361-367
22. Lee HY, Chun KH, Liu B, Wiehle SA, Cristiano RJ, Hong WK, Cohen P, Kurie JM (2002) Insulin-like growth factor-binding protein-3 inhibits the growth of non-small cell lung cancer. Cancer Res 62: 3530-3537
23. Chambers AF, Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89: 1260-1270
24. Waas ET, Wobbes T, Lomme RMLM, DeGroot J, Ruers T, Hendriks T (2003) Matrix metalloproteinase-2 and -9 activity in patients with colorectal cancer liver metastasis. Br J Surg 90: 1556-1564
25. Lee SW, Feingold DL, Carter JJ, Zhai C, Stapleton G, Gleason N, Whelan RL (2003) Peritoneal macrophage and blood monocyte functions after open and laparoscopic-assisted cecectomy in rats. Surg Endosc 17: 1996-2002
26. Owen CA, Hu Z, Barrick B, Shapiro SD (2003) Inducible expression of tissue inhibitor of metalloproteinases-resistant matrix metalloproteinase-9 on the cell surface of neutrophils. Am J Respir Cell Mol Biol 29: 283-294
27. Goetzl EJ, Banda MJ, Leppert D (1996) Matrix metalloproteinases in immunity. J Immunol 156: 1-4
28. Fowlkes JL, Thrailkill KM, Serra DM, Suzuki K, Nagase H (1995) Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases. Prog Growth Factor Res 6: 255-263
29. Fowlkes JL (1994) Degradation of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) by a metal-dependent protease produced by human fibroblasts. Endocrine 2: 63-68
30. Fowlkes JL, Serra DM, Nagase H, Thrailkill KM (1999) MMPs are IGFBP-degrading proteinases: implications for cell proliferation and tissue growth. Ann N Y Acad Sci 878: 696-699
31. Nagase H, Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274: 21491-21494
32. Nagase H (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem 378: 151-160
33. Robert V, Besse S, Sabri A, Silvestre JS, Assayag P, Nguyen VT, Swynghedauw B, Delcayre C (1997) Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart. Lab Invest 76: 729-738
34. Tyagi SC (1998) Dynamic role of extracellular matrix metalloproteinases in heart failure. Cardiovasc Pathol 7: 153-159
35. Roeb E, Dietrich CG, Winograd R, Arndt M, Breuer B, Fass J, Schumpelick V, Matern S (2001) Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma differential activity of matrix metalloproteinase-9. Cancer 92: 2680-2691
36. Modric T, Silha JV, Shi Z, Gui Y, Suwanichkul A, Durham SK, Powell DR, Murphy LJ (2001) Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice. Endocrinology 142: 1958-1967
37. Kirman I, Poltoratskaia N, Sylla P, Whelan RL (2004) Insulin-like growth factor-binding protein-3 inhibits growth of experimental colocarcinoma. Surgery 136: 205-209
38. Sylla P, Nihalani A, Whelan RL (2006) Microarray analysis of the differential effects of open and laparoscopic surgery on murine splenic T-cells. Surgery 139: 92-103